A diagnostic procedure designed for the swift detection of Hepatitis C virus antibodies in a blood sample. This type of assessment provides preliminary results significantly faster than traditional laboratory methods, often within minutes.
The availability of quick screening is crucial for prompt diagnosis and linkage to care. Early identification enables timely initiation of antiviral treatment, preventing progression to chronic liver disease, cirrhosis, and hepatocellular carcinoma. Its implementation facilitates immediate intervention, contributing to improved patient outcomes and reduced disease transmission. This technology represents a significant advancement over previous, more time-consuming methodologies.